Greenberg Traurig adds three shareholders from Weil

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Greenberg Traurig adds three shareholders from Weil

A team of three patent litigation partners is leaving Weil Gotshal & Manges to join Greenberg Traurig’s Washington, DC office.

Mark Davis, Stephen Shahida and Ronald Pabis have agreed to join Greenberg Traurig as shareholders, although the exact date of the move has yet to be determined.

Davis, who focuses on IP rights and associated antitrust issues, will join the firm as chair of its International Trade Commission practice.

Pabis focuses on patent trials, licensing and other technology-related disputes. He also has experience in Section 337 investigations before the ITC.

Shahida focuses on patent disputes. Prior to joining Weil Gotshal, he co-headed the Washington, DC IP litigation practice at McDermott Will & Emery.



more from across site and SHARED ros bottom lb

More from across our site

Stephenson Harwood’s trademark prosecution push and patent ambitions could complement Taylor Wessing’s remaining but depleted European IP strength following its UK arm’s departure
Gerben IP’s first woman partner, Sophie Edbrooke, explains how boutique life allowed her to broaden her expertise, take on leadership responsibilities and carve out a route to the top
INTA has a right to protect its Annual Meeting, but making it harder for others to hold similar events risks leaving delegates with a bigger travel bill
The firm says it hopes to capture patent litigation work in Texas by arming itself with experienced trial lawyers with venue expertise
Ken Iijima's arrival continues a trend of ex-Pizzeys practitioners joining RnB IP, whose co-founder says independent ownership and a lucrative compensation model have become attractive in a consolidating market
McDermott Will & Schulte lawyers explore why the UPC is seeing rapid adoption by medtech for fast-moving disputes, while pharma and biotech take a cautious, selective approach over revocation risks
IP firms may be growing more comfortable with external capital, but uncertainty over who could ultimately own the business is complicating the investment pitch
The former Western District of Texas judge addresses perceptions of his courtroom, reveals what comes next as he returns to practice at A&O Shearman and explains why marathon running is ‘cathartic’
International Anti-Counterfeiting Coalition says it has been blocked from hosting its annual event in the city, ending a long tradition of holding the gathering in the days leading up to INTA’s flagship event
The ITC is a powerful tool for litigators, practitioners say, as the threat of an exclusion order on a critical tech component could mean disrupting the entire data centre's operations
Gift this article